Industry: Pharmaceuticals, Biotechnology
AME is a wholly owned subsidiary of Eli Lilly and Company and a leader in applying directed molecular evolution to improve healthcare by optimizing and developing human biotherapeutics. Directed molecular evolution is a process for optimizing genes and proteins for specific commercial purposes. Since its inception, AME’s principal focus has been on applying its proprietary AMEsystem(TM) technology platform to human biotherapeutics, the largest market for directed molecular evolution. Biotherapeutics, or biopharmaceuticals, are protein pharmaceuticals such as antibodies, cytokines, hormones and enzymes. AME uses its proprietary technology to develop improved versions of currently marketed, FDA-approved biopharmaceuticals as well as novel human biotherapeutics. ( www.amevolution.com )
Applied Molecular Evolution , Inc.
3520 Dunhill St Ste B
San Diego, California 92121
USA
Tel: (858) 597-4990
Fax: (619) 597-4950